Physician profile

Laura Starkey

Nurse Practitioner · Fairlawn, OH

NPI 1336655984

$1,117.08

in general payments reported to CMS, 2019-2025

10 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$1,048.35

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbvie INC. $244.12 2024
Inspire Medical Systems, INC. $243.76 2024 Inspire
Alexion Pharmaceuticals, INC. $124.99 2024
Neurelis, INC. $113.47 2024 Valtoco
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $111.77 2024 Xifaxan
Otsuka Pharmaceutical Development & Commercialization, INC. $96.97 2024
Sanofi-Aventis U.S. LLC $90.22 2024
Novo Nordisk INC $50.00 2022
Indivior INC. $23.05 2023 Perseris
Abbott Laboratories $18.73 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Laura Starkey

$1,117.08

in general payments reported 2019-2025

Years
2021-2024
Top company
Abbvie INC.

https://glasscript.com/doctor/10995358/laura-starkey

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.